Find the Right Treatment in India

Search from 500+ procedures across top NABH & JCI accredited hospitals

Find Cost
Find Doctor
Find Hotels
Find Hospitals

Bleomycin TACE for Hemangioma Treatment in India

Released Date: 2026-05-10

Bleomycin TACE for Hepatic Hemangioma Treatment in India

A complete guide for international patients — procedure, results, costs and how Satyug Healthcare makes your journey seamless from the first consultation to recovery.

If you or a loved one has been diagnosed with a large liver hemangioma that is causing pain, abdominal discomfort or complications, you are not alone. Hepatic hemangiomas are the most common benign liver tumours worldwide, found in up to 20% of the general population. While most small hemangiomas require no treatment at all, giant hemangiomas — those larger than 5 cm — can cause significant symptoms and may need intervention. The good news is that surgery, once the only option, has largely been replaced by a safer, far less invasive procedure called Bleomycin TACE (Transarterial Chemoembolization) — and India is now one of the world's leading destinations for this procedure at a fraction of Western costs.

🩺 What is a Hepatic Hemangioma?

A hepatic (liver) hemangioma is a non-cancerous tumour made up of a cluster of abnormal blood vessels. It is not cancer and does not become cancer. It originates from the hepatic artery and is lined by endothelial cells. Hemangiomas are more common in women and are typically discovered accidentally during an ultrasound or CT scan done for an unrelated reason.

✅ Small Hemangioma (<5 cm)

Almost always asymptomatic. Requires only periodic imaging observation — no treatment needed in the vast majority of cases.

⚠️ Giant Hemangioma (>5 cm)

Symptomatic in 80–90% of cases. May require treatment when causing pain, compression of nearby organs, or rapid growth.

🔍 Symptoms — When Does a Hemangioma Become a Problem?

Small hemangiomas are asymptomatic in 80–86% of cases. However, giant hemangiomas are symptomatic in up to 90% of cases. Symptoms arise because the growing lesion compresses neighbouring structures — the stomach, bile duct, diaphragm and blood vessels.

Persistent pain or heaviness in the upper right abdomen
Nausea, vomiting and reduced appetite
Feeling of fullness after eating small amounts (early satiety)
Abdominal bloating and distension
Pain radiating to the right shoulder (capsular stretching)
Palpable abdominal mass in very large lesions
Rare but serious: Spontaneous rupture with internal bleeding
Kasabach-Merritt Syndrome — rare complication with abnormal clotting within the hemangioma

🔬 How is Hepatic Hemangioma Diagnosed?

Diagnosis is made through imaging alone. No biopsy is needed or recommended — the risk of bleeding from a biopsy outweighs any diagnostic benefit. Indian hospitals offer all required imaging with fast turnaround times.

Imaging Modality	Accuracy	Best Used For
Ultrasound (USG / CEUS)	Good	First detection, routine follow-up
CT Scan — Triple Phase	Very Good (90–95%)	Size measurement, pre-procedure planning
MRI — Gadolinium Contrast	Excellent (95–99%)	Gold standard — atypical or borderline lesions
DSA (during TACE)	Definitive	Maps feeding arteries precisely

💉 What is Bleomycin TACE and How Does it Work?

Bleomycin TACE — formally known as Superselective Transarterial Chemoembolization using Bleomycin–Lipiodol Emulsion — is a minimally invasive interventional radiology procedure now recognised as the preferred treatment for symptomatic giant hepatic hemangiomas, replacing surgery in most patients worldwide.

💡 The Core Principle

Since hemangiomas are fed exclusively by hepatic artery branches, blocking those feeding arteries while delivering bleomycin (a sclerosing agent) directly into the lesion causes the abnormal blood vessels to collapse, scar and shrink — without surgery, without general anaesthesia, and without removing any part of the liver.

Bleomycin damages the endothelial cells lining the abnormal vessels, triggering fibrosis and collapse. When mixed with lipiodol (an oily contrast agent), it forms a stable emulsion that concentrates within the hemangioma and persists for weeks, providing a sustained therapeutic effect.

Step-by-Step Procedure

Arterial Access
A small puncture is made in the common femoral artery (groin) under local anaesthesia. A 5–6F introducer sheath is placed. No general anaesthesia required.

Diagnostic Angiography
A catheter maps the hepatic artery blood supply, identifies all feeding arteries of the hemangioma and checks for arterio-portal shunts.

Superselective Catheterisation
A 2.4–2.7 Fr Progreat microcatheter is advanced into the specific feeding artery with extraordinary precision — as close to the hemangioma as possible.

Bleomycin–Lipiodol Injection
The bleomycin–lipiodol emulsion (15 mg bleomycin + 10–15 mL lipiodol) is slowly injected under fluoroscopic guidance until satisfactory filling of the hemangioma is confirmed.

Recovery
Catheter removed. Patient observed for 3–4 days. Most patients return to normal activity within one week of discharge.

📊 Published Results — What to Expect

Data from multiple international peer-reviewed studies (PubMed Central, MDPI) consistently demonstrate the following outcomes:

100%

Technical Success Rate

80.6%

≥50% Volume Reduction

63–100%

Symptom Relief Rate

Treatment Mortality

77.5% of patients achieved hemangioma coverage exceeding 75% on a single session. Maximum shrinkage is typically reached by the 12th month post-procedure. Long-term follow-up studies of over 5 years show durable results with no symptomatic recurrence in the majority of successfully treated patients.

Bleomycin TACE vs Surgery — Side by Side

Parameter	✅ Bleomycin TACE	🏥 Surgery
Anaesthesia	Local + Sedation	General Anaesthesia
Hospital Stay	3–4 Days	7–14 Days
Blood Loss Risk	Minimal	Significant (especially large lesions)
Mortality Risk	Near Zero	0.3–1% (major hepatic surgery)
Recovery Time	1–2 Weeks	4–8 Weeks
Clinical Success	80–100%	High but greater complication risk

⚠️ Possible Risks and Side Effects

Post-Embolization Syndrome (PES) — fever, fatigue, mild abdominal pain — occurs in ~45% of patients, resolves within 5–7 days with supportive care.
Hepatic Artery Dissection — rare (~3–5%), usually detected and managed during the same procedure.
Temporary Liver Enzyme Rise — common, normalises within 1–4 weeks.
Access Site Bruising — minor haematoma at groin puncture site in ~2–3% of patients.
Contrast Allergy — rare; managed with pre-procedure antihistamines and steroids.

Serious complications such as liver abscess or bile duct injury are exceedingly rare when performed by an experienced interventional radiologist using superselective technique.

🌍 Why Choose India for Bleomycin TACE?

🎓 World-Class Interventional Radiologists

India's leading IR specialists are trained at top institutions in the USA and Europe, performing superselective TACE with outcomes matching global benchmarks.

🏥 Advanced Technology

State-of-the-art biplane DSA suites, Progreat microcatheter systems and all embolic materials identical to leading European and US centres.

⏱️ No Waiting Lists

International patients are typically scheduled within days of arrival — not weeks or months as in many countries.

💰 60–80% Cost Savings

The same procedure that costs USD 15,000–30,000+ in the USA can be performed in India at USD 3,000–6,000 — without any compromise on quality.

Country	Approx. Cost of TACE (Total)
🇺🇸 United States (USA)	USD 15,000 – 30,000+
🇬🇧 United Kingdom	GBP 10,000 – 20,000+
🇩🇪 Germany	EUR 12,000 – 25,000+
🇮🇳 India	USD 3,000 – 6,000 (approx. ₹2.5–5 lakh)

Costs vary by hospital, city and case complexity. Contact Satyug Healthcare for a personalised estimate.

🤝 How Satyug Healthcare Helps You

Travelling abroad for medical care can feel overwhelming. Satyug Healthcare takes care of every detail so you can focus entirely on your treatment and recovery.

📋

Free Medical Opinion in 24–48 Hours
Share your CT scan, MRI and blood reports. We arrange a written opinion from a senior interventional radiologist at a JCI/NABH hospital — at no charge.

🏥

Hospital Selection Across India's Best
BLK-Max (New Delhi), Apollo Indraprastha (New Delhi), Medanta Medicity (Gurugram), Fortis Memorial Research Institute (Gurugram), Manipal Hospital Dwarka (Delhi), KIMS Hospitals (Hyderabad).

✈️

Complete End-to-End Coordination
Airport pick-up → hotel accommodation → pre-procedure tests → TACE procedure → hospital stay → discharge → follow-up imaging. We manage everything.

📄

Medical Visa Invitation Letter
We provide the official invitation letter and guide you through the Indian medical visa process from your home country.

🌐

Language Support
Our team communicates in English, Arabic, Russian, French and other languages — no communication barrier between you and your medical team.

🔄

Post-Procedure Remote Follow-Up
After returning home, we coordinate your follow-up CT/MRI review with your treating interventional radiologist in India via video consultation.

❓ Frequently Asked Questions

Q. Is Bleomycin TACE safe for liver hemangioma?

Yes. Multiple published studies involving hundreds of patients report no procedure-related mortality, with a low rate of serious complications. Post-embolization syndrome occurs in ~45% of patients but resolves within a week with supportive care.

Q. How many TACE sessions will I need?

Most patients require one to two sessions. A single superselective TACE is sufficient for the majority. A second session may be considered at 6–12 months if imaging shows incomplete response.

Q. How much will the hemangioma shrink?

Clinical success (≥50% volume reduction) is achieved in over 80% of patients. Some patients see a reduction of 70–90% by the 12-month follow-up. Maximum shrinkage is reached at 12 months post-procedure.

Q. How long do I need to stay in India?

We recommend a total stay of approximately 10–14 days — covering pre-procedure workup (1–2 days), the TACE procedure and hospital stay (3–4 days), and post-procedure recovery and early imaging before returning home.

Q. Can a hemangioma come back after TACE?

In patients who achieve complete embolization, recurrence is uncommon. Long-term follow-up studies of more than 5 years show durable results with no symptomatic recurrence in the majority of successfully treated patients.

Q. I have multiple hemangiomas — can I still have TACE?

Yes. Patients with multiple hemangiomas have been successfully treated. The interventional radiologist maps all lesions during angiography and embolises each feeding artery selectively in the same session where possible.

Ready to Explore Treatment in India?

Share your CT scan or MRI reports with us and receive a FREE written medical opinion from a senior interventional radiologist at a JCI/NABH hospital within 24–48 hours — no obligation.

📞 +91-8860606766 | +91-9910655125

✉ query@satyughealthcare.com